Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RBX2660 for Recurrent MDRO Urinary Tract Infections
NCT03367910Phase 2Completed
- Sponsor
- Washington University School of Medicine
- Start
- Feb 2018
- Primary completion
- Dec 2021
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of fecal microbiome transplant in urinary tract infection (UTI), sponsored by Washington University School of Medicine. Started Feb 2018; status: completed.
02
Drugs
fecal microbiome transplant
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT03367910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03367910.